Table 1. Sample sizes.
Denver | NIDA | Oakland | Sacramento | Seattle | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TOTAL | >1 | TOTAL | >1 | PCA | TOTAL | >1 | PCA | TOTAL | >1 | PCA | TOTAL | >1 | |
CBD | 1141 | 42 | 98 | 56 | 90 | 755 | 110 | 481 | 981 | 101 | 981 | 103 | 4 |
CBN | — | — | 98 | — | 90 | 481 | — | 481 | 981 | — | 981 | — | — |
THC | 1141 | 1112 | 98 | 64 | 90 | 755 | 692 | 481 | 981 | 952 | 981 | 103 | 103 |
CBG | 992 | 98 | 96 | 1 | 90 | 481 | 41 | 481 | 981 | 259 | 981 | 103 | 12 |
THC-V | 992 | 12 | 96 | — | 90 | 481 | 6 | 481 | 981 | 21 | 981 | 103 | 1 |
CBC | — | — | 96 | — | 90 | 481 | — | 481 | 981 | 2 | 981 | — | — |
THC & CBD >1 | 21 | — | 24 | — | — | 77 | — | — | 81 | — | — | 4 | — |
Sample sizes for each cannabinoid at the different locations. Denver and Seattle lack samples for CBN and CBC. The first column represents the total sample sizes for each cannabinoid, the >1 column represents the number of samples that produced more than 1% content of each cannabinoid. No location had varieties that produced >1% CBN or CBC. The last column represents the sample sizes used for the PCA, which was performed only with samples from Oakland, Sacramento, and NIDA. The last row represents the samples that produce more than 1% for both THC and CBD.